Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer
Status:
Completed
Trial end date:
2002-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of pyrazoloacridine in treating women who
have refractory metastatic breast cancer.